Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Daniel Bowles

Concepts (347)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
30
2024
2061
3.560
 Why?
Head and Neck Neoplasms
16
2023
544
3.060
 Why?
Salivary Gland Neoplasms
8
2023
33
3.040
 Why?
Carcinoma, Squamous Cell
14
2019
626
2.370
 Why?
Protein Kinase Inhibitors
14
2024
891
2.300
 Why?
Pyridines
11
2024
478
2.130
 Why?
Thyroid Neoplasms
9
2024
310
2.020
 Why?
Neoplasm Recurrence, Local
7
2023
964
1.770
 Why?
Molecular Targeted Therapy
7
2021
390
1.760
 Why?
Carcinoma, Non-Small-Cell Lung
8
2023
1052
1.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
14
2024
1565
1.650
 Why?
Neoplasms
20
2024
2470
1.620
 Why?
Protein-Tyrosine Kinases
4
2021
432
1.510
 Why?
Lung Neoplasms
10
2023
2344
1.440
 Why?
Anilides
6
2024
73
1.430
 Why?
Gonanes
7
2016
27
1.420
 Why?
Proto-Oncogene Proteins
6
2021
638
1.370
 Why?
Biomarkers, Tumor
8
2020
1181
1.330
 Why?
Thyroid Carcinoma, Anaplastic
3
2020
35
1.330
 Why?
Cetuximab
7
2018
94
1.320
 Why?
Adenocarcinoma
7
2024
898
1.300
 Why?
Phosphatidylinositol 3-Kinases
8
2017
359
0.870
 Why?
Mutation
13
2024
3717
0.810
 Why?
Carcinoma
3
2019
217
0.760
 Why?
Neoplasm Staging
15
2019
1295
0.730
 Why?
Phytotherapy
2
2012
79
0.730
 Why?
Drugs, Investigational
2
2011
32
0.720
 Why?
Cisplatin
6
2024
300
0.710
 Why?
Pyrazoles
5
2023
405
0.680
 Why?
Disease-Free Survival
10
2017
648
0.660
 Why?
Neoplasms, Second Primary
1
2021
106
0.660
 Why?
Papillomaviridae
4
2019
114
0.650
 Why?
Antineoplastic Agents, Immunological
2
2018
181
0.650
 Why?
Quinolines
5
2024
156
0.640
 Why?
Carcinoma, Renal Cell
3
2017
180
0.640
 Why?
Taxoids
3
2015
98
0.640
 Why?
Humans
89
2024
129650
0.640
 Why?
Hedgehog Proteins
3
2015
188
0.630
 Why?
Drug Resistance, Neoplasm
8
2024
759
0.610
 Why?
Marijuana Smoking
2
2012
247
0.590
 Why?
Tumor Suppressor Proteins
2
2018
317
0.580
 Why?
Middle Aged
43
2024
31154
0.580
 Why?
Pyrimidines
5
2023
459
0.580
 Why?
Colorectal Neoplasms
2
2016
752
0.570
 Why?
Aged
39
2024
22103
0.560
 Why?
Kidney Neoplasms
3
2017
350
0.560
 Why?
Carcinoma, Mucoepidermoid
1
2017
17
0.550
 Why?
Ubiquitin Thiolesterase
1
2017
42
0.540
 Why?
Carcinoma, Transitional Cell
4
2017
60
0.530
 Why?
Carcinoma, Ductal
1
2016
11
0.520
 Why?
Adenoma, Pleomorphic
1
2016
9
0.520
 Why?
Sulfones
2
2014
108
0.520
 Why?
Gene Rearrangement
2
2018
148
0.520
 Why?
Glycine
2
2014
165
0.510
 Why?
Cannabinoids
2
2024
153
0.510
 Why?
Maximum Tolerated Dose
5
2017
193
0.470
 Why?
Enzyme Inhibitors
3
2014
827
0.440
 Why?
Melanoma
1
2021
730
0.440
 Why?
Drug Interactions
6
2017
394
0.440
 Why?
Pyrroles
1
2014
202
0.430
 Why?
Male
44
2024
63681
0.430
 Why?
Signal Transduction
8
2018
4925
0.420
 Why?
Iodine Radioisotopes
5
2024
143
0.420
 Why?
Gene Fusion
3
2023
24
0.420
 Why?
Phenylurea Compounds
4
2024
89
0.420
 Why?
Genetic Variation
1
2018
937
0.410
 Why?
Receptor Protein-Tyrosine Kinases
2
2012
231
0.410
 Why?
Female
45
2024
68776
0.410
 Why?
Lymph Nodes
4
2017
472
0.400
 Why?
Indazoles
3
2019
65
0.390
 Why?
Aged, 80 and over
15
2024
7086
0.390
 Why?
Treatment Outcome
15
2024
10230
0.380
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2017
81
0.380
 Why?
Quinazolines
1
2013
244
0.380
 Why?
Antibodies, Monoclonal, Humanized
4
2024
759
0.380
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2012
118
0.370
 Why?
Neoplasm Metastasis
6
2021
610
0.350
 Why?
Proto-Oncogene Proteins c-ret
4
2023
30
0.330
 Why?
Adult
26
2024
35576
0.330
 Why?
Prognosis
9
2021
3794
0.310
 Why?
Papillomavirus Infections
3
2022
297
0.300
 Why?
ErbB Receptors
4
2017
607
0.290
 Why?
Pharmacogenomic Variants
2
2018
35
0.280
 Why?
Nitriles
2
2022
172
0.280
 Why?
Urologic Neoplasms
2
2017
26
0.270
 Why?
Xenograft Model Antitumor Assays
7
2024
814
0.270
 Why?
Carcinoma, Ductal, Breast
1
2007
82
0.270
 Why?
Platinum
2
2024
44
0.260
 Why?
Mitoxantrone
1
2006
14
0.260
 Why?
Enterobacter
1
2006
7
0.260
 Why?
Tooth Diseases
1
2006
13
0.260
 Why?
Gene Expression Profiling
5
2018
1706
0.250
 Why?
Esophageal and Gastric Varices
1
2006
37
0.250
 Why?
Enterobacteriaceae Infections
1
2006
41
0.250
 Why?
Benzamides
2
2019
207
0.250
 Why?
Salivary Glands
2
2023
29
0.250
 Why?
Oropharyngeal Neoplasms
2
2016
48
0.250
 Why?
Animals
16
2024
35361
0.250
 Why?
Acute Kidney Injury
3
2018
790
0.250
 Why?
Chemoradiotherapy
4
2020
210
0.240
 Why?
Clinical Trials as Topic
3
2018
1004
0.240
 Why?
Registries
2
2016
1896
0.240
 Why?
Serotonin 5-HT3 Receptor Antagonists
1
2024
5
0.240
 Why?
Proto-Oncogene Proteins B-raf
2
2024
212
0.230
 Why?
Immunotherapy
2
2023
592
0.230
 Why?
Receptors, Estrogen
1
2007
426
0.230
 Why?
Cannabis
1
2011
465
0.230
 Why?
Antiemetics
1
2024
41
0.230
 Why?
Urinary Bladder Neoplasms
2
2017
228
0.220
 Why?
Liver Cirrhosis
1
2006
280
0.220
 Why?
Models, Biological
3
2024
1722
0.220
 Why?
Carcinoma, Adenoid Cystic
1
2023
18
0.220
 Why?
Bacteremia
1
2006
197
0.220
 Why?
Combined Modality Therapy
4
2018
1206
0.220
 Why?
Gene Expression Regulation, Neoplastic
3
2019
1356
0.210
 Why?
Administration, Oral
3
2014
786
0.210
 Why?
Phenylthiohydantoin
1
2022
44
0.200
 Why?
Survival Rate
5
2021
1877
0.190
 Why?
Medical Marijuana
1
2024
111
0.190
 Why?
Referral and Consultation
1
2007
732
0.190
 Why?
Breast Neoplasms
2
2019
2142
0.190
 Why?
Drug Evaluation, Preclinical
2
2013
171
0.190
 Why?
Chemotherapy, Adjuvant
3
2017
381
0.190
 Why?
Radiation Pneumonitis
1
2021
28
0.190
 Why?
Survival Analysis
4
2020
1274
0.190
 Why?
Carcinoma, Neuroendocrine
1
2021
32
0.180
 Why?
TOR Serine-Threonine Kinases
2
2016
396
0.180
 Why?
Adrenal Cortex Neoplasms
1
2021
60
0.170
 Why?
Adrenocortical Carcinoma
1
2021
63
0.170
 Why?
Disease Susceptibility
2
2020
333
0.170
 Why?
SEER Program
1
2021
206
0.170
 Why?
Cystectomy
2
2017
38
0.170
 Why?
Gene Expression
2
2015
1472
0.170
 Why?
Receptors, Nerve Growth Factor
1
2019
17
0.170
 Why?
Kaplan-Meier Estimate
3
2017
857
0.170
 Why?
United States
8
2021
13903
0.160
 Why?
Leukemia, Myeloid, Acute
1
2006
592
0.160
 Why?
Radiosurgery
1
2022
321
0.160
 Why?
DNA Mutational Analysis
2
2018
387
0.160
 Why?
Tracheal Neoplasms
1
2019
9
0.160
 Why?
Lymph Node Excision
2
2017
164
0.160
 Why?
Positron Emission Tomography Computed Tomography
1
2020
85
0.160
 Why?
Smad4 Protein
1
2019
38
0.150
 Why?
Prostatic Neoplasms
1
2006
1016
0.150
 Why?
Genetic Heterogeneity
1
2019
58
0.150
 Why?
Benzazepines
1
2018
40
0.150
 Why?
Genomics
3
2021
716
0.150
 Why?
Alphapapillomavirus
2
2016
40
0.150
 Why?
Palliative Care
2
2018
725
0.150
 Why?
Disease Management
2
2020
589
0.150
 Why?
Risk
1
2021
854
0.150
 Why?
Chromosome Aberrations
1
2019
150
0.150
 Why?
DNA Mismatch Repair
1
2018
47
0.140
 Why?
Receptor, ErbB-2
2
2019
326
0.140
 Why?
Tissue Fixation
1
2017
34
0.140
 Why?
Paraffin Embedding
1
2017
29
0.140
 Why?
Oncogenes
1
2018
113
0.140
 Why?
Erlotinib Hydrochloride
1
2017
70
0.140
 Why?
Smokers
1
2018
138
0.140
 Why?
Nasopharyngeal Neoplasms
1
2017
16
0.140
 Why?
Formaldehyde
1
2017
60
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
129
0.140
 Why?
Gene Deletion
1
2019
379
0.140
 Why?
Health Services Needs and Demand
1
2019
264
0.140
 Why?
Neoplasm Grading
1
2018
285
0.140
 Why?
DNA, Neoplasm
1
2017
159
0.140
 Why?
Induction Chemotherapy
1
2017
70
0.130
 Why?
Gene Frequency
1
2018
503
0.130
 Why?
Chemoradiotherapy, Adjuvant
1
2016
42
0.130
 Why?
Salivary Ducts
1
2016
2
0.130
 Why?
Hospice and Palliative Care Nursing
1
2018
74
0.130
 Why?
Laryngeal Neoplasms
1
2016
31
0.130
 Why?
Patient Navigation
1
2018
79
0.130
 Why?
Prospective Studies
7
2024
7133
0.130
 Why?
Carboplatin
1
2016
140
0.130
 Why?
Nomograms
1
2016
47
0.130
 Why?
Muscle, Smooth
1
2017
157
0.130
 Why?
Young Adult
5
2021
12426
0.130
 Why?
Database Management Systems
1
2016
48
0.130
 Why?
Retrospective Studies
8
2021
14518
0.130
 Why?
Disease Progression
4
2018
2635
0.130
 Why?
Computational Biology
2
2018
599
0.130
 Why?
Population Surveillance
1
2019
439
0.130
 Why?
Dose-Response Relationship, Drug
3
2017
2012
0.120
 Why?
Incidence
2
2019
2644
0.120
 Why?
Angiopoietin-1
1
2015
11
0.120
 Why?
Angiopoietin-2
1
2015
15
0.120
 Why?
Radiotherapy
1
2016
188
0.120
 Why?
Bone Neoplasms
1
2017
231
0.120
 Why?
Genetic Testing
1
2018
428
0.120
 Why?
Zinc Finger Protein GLI1
1
2014
23
0.120
 Why?
Retreatment
1
2014
70
0.120
 Why?
Hospice Care
1
2018
200
0.120
 Why?
Piperazines
2
2018
342
0.110
 Why?
Neoplasms, Unknown Primary
1
2014
13
0.110
 Why?
Response Evaluation Criteria in Solid Tumors
1
2014
17
0.110
 Why?
Paclitaxel
1
2015
217
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2016
431
0.110
 Why?
Neoplastic Stem Cells
1
2018
380
0.110
 Why?
Patient Satisfaction
1
2018
634
0.110
 Why?
Sulfonamides
1
2017
496
0.110
 Why?
High-Throughput Nucleotide Sequencing
1
2017
487
0.110
 Why?
Pilot Projects
2
2015
1587
0.110
 Why?
Proportional Hazards Models
4
2017
1201
0.110
 Why?
Promoter Regions, Genetic
1
2018
1207
0.110
 Why?
Veratrum Alkaloids
1
2013
19
0.110
 Why?
ras Proteins
1
2014
144
0.100
 Why?
Cell Cycle Proteins
2
2014
586
0.100
 Why?
PTEN Phosphohydrolase
1
2014
161
0.100
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
259
0.100
 Why?
Risk Assessment
2
2019
3240
0.100
 Why?
Imatinib Mesylate
1
2012
76
0.100
 Why?
Dasatinib
1
2012
54
0.100
 Why?
Recombinant Fusion Proteins
1
2015
643
0.100
 Why?
Thiazoles
1
2012
117
0.100
 Why?
Hematopoietic Stem Cells
1
2015
381
0.090
 Why?
Aniline Compounds
1
2012
98
0.090
 Why?
Biomarkers
3
2018
3973
0.090
 Why?
Mice
7
2024
16937
0.090
 Why?
Smoking
1
2019
1501
0.090
 Why?
Proto-Oncogene Proteins c-met
1
2012
74
0.090
 Why?
Biological Availability
1
2011
147
0.090
 Why?
Adolescent
5
2022
20393
0.090
 Why?
Imidazoles
1
2012
234
0.090
 Why?
Propensity Score
3
2017
265
0.090
 Why?
Carcinoma, Basal Cell
1
2012
74
0.090
 Why?
Phosphatidylinositol 3-Kinase
1
2011
26
0.090
 Why?
Evidence-Based Medicine
2
2012
718
0.090
 Why?
Tumor Microenvironment
1
2015
634
0.090
 Why?
Vascular Endothelial Growth Factor A
2
2024
530
0.090
 Why?
Cell Line, Tumor
4
2024
3215
0.090
 Why?
Algorithms
1
2018
1622
0.090
 Why?
Phenotype
1
2018
3076
0.080
 Why?
Genetic Predisposition to Disease
1
2018
2282
0.080
 Why?
Kidney
1
2017
1385
0.080
 Why?
Adaptation, Psychological
1
2014
617
0.080
 Why?
Brain Neoplasms
1
2018
1171
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2024
107
0.080
 Why?
Multivariate Analysis
3
2017
1502
0.080
 Why?
Cohort Studies
4
2022
5420
0.070
 Why?
Axilla
1
2007
45
0.070
 Why?
Neoadjuvant Therapy
2
2022
383
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2019
50
0.070
 Why?
RNA, Messenger
1
2014
2708
0.070
 Why?
Caregivers
1
2014
815
0.070
 Why?
Sentinel Lymph Node Biopsy
1
2007
107
0.070
 Why?
Mastectomy
1
2007
131
0.070
 Why?
Transcription Factors
1
2014
1651
0.070
 Why?
Ligation
1
2006
87
0.060
 Why?
Stress, Psychological
1
2014
1066
0.060
 Why?
Creatinine
2
2018
491
0.060
 Why?
Lymphatic Metastasis
2
2017
320
0.060
 Why?
Fatal Outcome
1
2006
300
0.060
 Why?
Pain
1
2011
789
0.060
 Why?
Neoplasm Invasiveness
2
2017
485
0.060
 Why?
Double-Blind Method
2
2021
1876
0.060
 Why?
Receptors, Progesterone
1
2007
343
0.060
 Why?
Granisetron
1
2024
5
0.060
 Why?
Quinuclidines
1
2024
9
0.060
 Why?
Risk Factors
1
2019
9765
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
121
0.060
 Why?
Ondansetron
1
2024
15
0.060
 Why?
Isoquinolines
1
2024
41
0.060
 Why?
Skin Neoplasms
1
2012
825
0.060
 Why?
Neoplasm Proteins
1
2007
424
0.060
 Why?
Glomerular Filtration Rate
2
2018
711
0.060
 Why?
Demography
2
2015
279
0.050
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2023
84
0.050
 Why?
Benzimidazoles
1
2024
162
0.050
 Why?
Recurrence
2
2018
1007
0.050
 Why?
Databases, Factual
2
2019
1269
0.050
 Why?
Androgen Antagonists
1
2022
79
0.050
 Why?
Four-Dimensional Computed Tomography
1
2021
29
0.050
 Why?
Quality of Life
1
2013
2704
0.050
 Why?
Immunohistochemistry
2
2018
1698
0.050
 Why?
Pulmonary Ventilation
1
2021
77
0.050
 Why?
Receptors, Androgen
1
2022
147
0.040
 Why?
Radiotherapy Planning, Computer-Assisted
1
2021
124
0.040
 Why?
Receptor, trkA
1
2019
16
0.040
 Why?
Receptor, trkC
1
2019
10
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
72
0.040
 Why?
Receptor, trkB
1
2019
30
0.040
 Why?
Trastuzumab
1
2019
101
0.040
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2020
169
0.040
 Why?
Radiotherapy, Image-Guided
1
2018
34
0.040
 Why?
Phthalazines
1
2018
41
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
315
0.040
 Why?
Organic Cation Transporter 2
1
2017
8
0.040
 Why?
Glutathione S-Transferase pi
1
2017
9
0.040
 Why?
Multidrug Resistance-Associated Proteins
1
2017
37
0.040
 Why?
Retroperitoneal Space
1
2017
16
0.030
 Why?
Organic Cation Transport Proteins
1
2017
30
0.030
 Why?
Urinary Diversion
1
2017
12
0.030
 Why?
Membrane Glycoproteins
1
2019
474
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
43
0.030
 Why?
Margins of Excision
1
2017
38
0.030
 Why?
Social Work
1
2018
83
0.030
 Why?
Tumor Cells, Cultured
1
2019
940
0.030
 Why?
Laryngectomy
1
2016
15
0.030
 Why?
Immunophenotyping
1
2018
311
0.030
 Why?
Hospitals, Veterans
1
2018
255
0.030
 Why?
Oncologists
1
2017
35
0.030
 Why?
Kidney Function Tests
1
2017
152
0.030
 Why?
Disease Models, Animal
2
2018
4063
0.030
 Why?
Pelvis
1
2017
104
0.030
 Why?
Carcinogenesis
1
2018
213
0.030
 Why?
Viral Core Proteins
1
2016
21
0.030
 Why?
Cation Transport Proteins
1
2017
132
0.030
 Why?
Heart
1
2020
637
0.030
 Why?
Regression Analysis
1
2018
993
0.030
 Why?
Anti-Bacterial Agents
1
2006
1717
0.030
 Why?
Radiotherapy, Adjuvant
1
2016
210
0.030
 Why?
Internationality
1
2016
149
0.030
 Why?
Random Allocation
1
2016
346
0.030
 Why?
Antibodies, Neoplasm
1
2015
35
0.030
 Why?
Robotic Surgical Procedures
1
2017
115
0.030
 Why?
Biopsy, Large-Core Needle
1
2014
13
0.030
 Why?
Myocardium
1
2020
980
0.030
 Why?
Analysis of Variance
1
2017
1288
0.030
 Why?
Bone Marrow
1
2015
271
0.030
 Why?
Receptor, Notch2
1
2013
15
0.030
 Why?
Receptor Cross-Talk
1
2013
21
0.030
 Why?
Receptor, Notch1
1
2013
61
0.030
 Why?
Pandemics
1
2021
1488
0.020
 Why?
Metabolic Clearance Rate
1
2012
118
0.020
 Why?
Psychiatric Status Rating Scales
1
2014
529
0.020
 Why?
Gene Silencing
1
2013
190
0.020
 Why?
Transcriptome
1
2018
887
0.020
 Why?
Needs Assessment
1
2014
360
0.020
 Why?
Nausea
1
2012
110
0.020
 Why?
Logistic Models
1
2017
1988
0.020
 Why?
Vomiting
1
2012
128
0.020
 Why?
Area Under Curve
1
2012
304
0.020
 Why?
Mice, Nude
1
2013
683
0.020
 Why?
Diarrhea
1
2012
180
0.020
 Why?
Blotting, Western
1
2013
1205
0.020
 Why?
Fatigue
1
2012
318
0.020
 Why?
Drug Administration Schedule
1
2012
769
0.020
 Why?
Cell Proliferation
1
2017
2391
0.020
 Why?
Time Factors
1
2019
6556
0.020
 Why?
Lung
1
2021
3930
0.020
 Why?
Age Factors
1
2016
3144
0.020
 Why?
Colorado
1
2018
4421
0.020
 Why?
Follow-Up Studies
1
2016
4897
0.020
 Why?
Cytokines
1
2015
2017
0.020
 Why?
Surveys and Questionnaires
1
2018
5406
0.020
 Why?
Cross-Sectional Studies
1
2014
5066
0.010
 Why?
Bowles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (347) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)